Search Results - "Bequet, Monica"
-
1
Oncogenes and tumor angiogenesis: The HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner
Published in Oncogene (21-09-2000)“…Like other types of pre-malignant lesions and carcinoma, angiogenesis is associated with high-grade cervical dysplasia and with invasive squamous carcinoma of…”
Get full text
Journal Article -
2
Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate
Published in Vaccines (Basel) (03-06-2022)“…COVID-19 is a respiratory viral disease caused by a new coronavirus called SARS-CoV-2. This disease has spread rapidly worldwide with a high rate of morbidity…”
Get full text
Journal Article -
3
Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF
Published in Platelets (Edinburgh) (03-10-2022)“…CIGB-247 is a vascular endothelial growth factor (VEGF)-based active immunotherapy and it is currently under investigation for cancer treatment. This specific…”
Get full text
Journal Article -
4
Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels?
Published in BMC research notes (10-06-2019)“…Vascular endothelial growth factor (VEGF) is involved in physiological angiogenesis, but also is considered one of the key factors that promotes tumor…”
Get full text
Journal Article -
5
Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program
Published in BMC immunology (14-03-2020)“…CIGB-247 is a cancer therapeutic vaccine that uses as antigen a variant of human vascular endothelial growth factor (VEGF) mixed with the bacterially-derived…”
Get full text
Journal Article -
6
Evaluation of methodologies to determine the effect of specific active immunotherapy on VEGF levels in phase I clinical trial patients with advanced solid tumors
Published in Heliyon (01-11-2018)“…Two phase I clinical trials were conducted to evaluate, among other parameters, the humoral response elicited by a vascular endothelial growth factor…”
Get full text
Journal Article -
7
Comparative in vitro and experimental in vivo studies of the anti-epidermal growth factor receptor antibody nimotuzumab and its aglycosylated form produced in transgenic tobacco plants
Published in Plant biotechnology journal (01-01-2013)“…A broad variety of foreign genes can be expressed in transgenic plants, which offer the opportunity for large-scale production of pharmaceutical proteins, such…”
Get more information
Journal Article -
8
Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and blood
Published in Clinical immunology communications (01-12-2022)“…We conducted an experimental protocol with a nasal recombinant IFNα-2b formulation (Nasalferon) in 12 healthy volunteers who received 1 MIU per nostril twice a…”
Get full text
Journal Article -
9
CIGB-258, péptido inhibidor de la hiperinflamación en pacientes con COVID-19
Published in Anales de la Academia de Ciencias de Cuba (01-01-2022)“…Introducción. El CIGB-258 es un péptido, cuyo mecanismo de acción se ha asociado con la inhibición de la inflamación. El presente trabajo tiene como objetivo…”
Get full text
Journal Article -
10
Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice
Published in Angiogenesis (London) (01-03-2007)“…Passive immunotherapy against soluble pro-angiogenic factors and/or their receptors in endothelial cells has become a promising approach in cancer…”
Get full text
Journal Article -
11
Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine
Published in Vaccine (16-06-2017)“…Highlights • Specific immune response after chronic immunization with CIGB-247 was studied. • We evaluated eight patients after three years of vaccinations. •…”
Get full text
Journal Article -
12
Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials
Published in Journal of immunological methods (01-01-2022)“…COVID-19 pandemic poses a serious threat to human health; it has completely disrupted global stability, making vaccine development an important goal to…”
Get full text
Journal Article -
13
HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis
Published in Euroasian journal of hepato-gastroenterology (01-07-2021)“…More than 180 million people have been infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and more than 4 million coronavirus…”
Get full text
Journal Article -
14
Biologically active vascular endothelial growth factor as a bacterial recombinant glutathione S-transferase fusion protein
Published in Biotechnology and applied biochemistry (01-04-2006)“…Human VEGF121 (vascular endothelial growth factor isoform 121) was produced as a recombinant fusion protein with GST (glutathione S‐transferase) in Escherichia…”
Get full text
Journal Article -
15
Specific active immunotherapy with the HEBERSaVax VEGF-based cancer vaccine: From bench to bedside
Published in Seminars in oncology (01-01-2018)“…HEBERSaVax is a cancer therapeutic vaccine candidate based on the combination of a recombinant antigen representative of human vascular endothelial growth…”
Get full text
Journal Article -
16
Targeting the hydrophilic regions of recombinant proteins by MS via in-solution buffer-free trypsin digestion
Published in European journal of mass spectrometry (Chichester, England) (01-06-2020)“…A desalting step using reversed phase chromatography is a common practice prior to mass spectrometry analysis of proteolytic digests in spite of the…”
Get full text
Journal Article -
17
Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds
Published in International wound journal (01-12-2019)“…Diabetic foot ulcer is one of the most frightened diabetic complications leading to amputation disability and early mortality. Diabetic wounds exhibit a…”
Get full text
Journal Article -
18
A multivalent recombinant antibody fragment specific for carcinoembryonic antigen
Published in Biotechnology and applied biochemistry (01-01-2006)“…In the present paper we report the development of a bivalent scFv (single‐chain Fv) antibody fragment, starting from a mouse mAb (monoclonal antibody) specific…”
Get full text
Journal Article -
19
CIGB-247: A VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors
Published in Vaccine (27-02-2012)“…Highlights ► Antimetastatic effects of a VEGF based active immunotherapy: CIGB-247. ► CIGB-247 is a cancer therapeutic, based on recombinant modified VEGF as…”
Get full text
Journal Article -
20
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice
Published in Vaccine (16-02-2022)“…Since the beginning of the COVID-19 pandemic, the development of effective vaccines against this pathogen has been a priority for the scientific community…”
Get full text
Journal Article